Evelyne Lerut
Evelyne Lerut
Professor of Translational Cell & Tissue Research
Verified email at
Cited by
Cited by
Banff 07 classification of renal allograft pathology: updates and future directions
K Solez, RB Colvin, LC Racusen, M Haas, B Sis, M Mengel, PF Halloran, ...
American journal of transplantation 8 (4), 753-760, 2008
Banff’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (’CAN’)
K Solez, RB Colvin, LC Racusen, B Sis, PF Halloran, PE Birk, ...
American Journal of Transplantation 7 (3), 518-526, 2007
Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients
H Vlaminck, B Maes, G Evers, G Verbeke, E Lerut, B Van Damme, ...
American Journal of transplantation 4 (9), 1509-1513, 2004
Mapping of pelvic lymph node metastases in prostate cancer
S Joniau, L Van den Bergh, E Lerut, CM Deroose, K Haustermans, ...
European urology 63 (3), 450-458, 2013
CYP3A5 and CYP3A4 but not MDR1 Single‐nucleotide Polymorphisms Determine Long‐term Tacrolimus Disposition and Drug‐related Nephrotoxicity in Renal†…
DRJ Kuypers, H de Jonge, M Naesens, E Lerut, K Verbeke, ...
Clinical pharmacology & therapeutics 82 (6), 711-725, 2007
Intrarenal resistive index after renal transplantation
M Naesens, L Heylen, E Lerut, K Claes, L De Wever, F Claus, R Oyen, ...
New England Journal of Medicine 369 (19), 1797-1806, 2013
Adjuvant low‐dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients
DRJ Kuypers, AK Vandooren, E Lerut, P Evenepoel, K Claes, R Snoeck, ...
American Journal of Transplantation 5 (8), 1997-2004, 2005
Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology
S Isebaert, L Van den Bergh, K Haustermans, S Joniau, E Lerut, ...
Journal of magnetic resonance imaging 37 (6), 1392-1401, 2013
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate†…
T Budiharto, S Joniau, E Lerut, L Van den Bergh, F Mottaghy, ...
European urology 60 (1), 125-130, 2011
Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure
M ŽivnŠ, H HůlkovŠ, M Matignon, K HodaňovŠ, P Vylet'al, M KalbŠčovŠ, ...
The American Journal of Human Genetics 85 (2), 204-213, 2009
Expression of complement components differs between kidney allografts from living and deceased donors
M Naesens, L Li, L Ying, P Sansanwal, TK Sigdel, SC Hsieh, N Kambham, ...
Journal of the American Society of Nephrology 20 (8), 1839-1851, 2009
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts
M Naesens, E Lerut, H de Jonge, B Van Damme, Y Vanrenterghem, ...
Journal of the American Society of Nephrology 20 (11), 2468-2480, 2009
High‐level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB
T Van de Sande, T Roskams, E Lerut, S Joniau, H Van Poppel, ...
The Journal of Pathology: A Journal of the Pathological Society of Great†…, 2005
The histology of kidney transplant failure: a long-term follow-up study
M Naesens, DRJ Kuypers, K De Vusser, P Evenepoel, K Claes, ...
Transplantation 98 (4), 427-435, 2014
Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients
DRJ Kuypers, M Naesens, H de Jonge, E Lerut, K Verbeke, ...
Therapeutic drug monitoring 32 (4), 394-404, 2010
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2†…
B Kneitz, M Krebs, C Kalogirou, M Schubert, S Joniau, H van Poppel, ...
Cancer research 74 (9), 2591-2603, 2014
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
B Beuselinck, P Wolter, A Karadimou, R Elaidi, H Dumez, A Rogiers, ...
British Journal of Cancer 107 (10), 1665-1671, 2012
High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients
T Vanhove, T Vermeulen, P Annaert, E Lerut, DRJ Kuypers
American Journal of Transplantation 16 (10), 2954-2963, 2016
Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome
A Senev, M Coemans, E Lerut, V Van Sandt, L DaniŽls, D Kuypers, ...
American Journal of Transplantation 19 (3), 763-780, 2019
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial
P SchŲffski, A Wozniak, B Escudier, P Rutkowski, A Anthoney, S Bauer, ...
European Journal of Cancer 87, 147-163, 2017
The system can't perform the operation now. Try again later.
Articles 1–20